The results of the ENOVA survey on research topics and future networking interests are now ready here
News
Remember to apply for TRANSVAC2 Vaccine Development Services before 15 January 2022
Sign up for a new training course in adjuvants and formulation March 21-22, 2022 in Geneva Switzerland
More info here
ENOVA STRATEGY ON VIRTUAL NETWORKING
Brankica Filipic has been awarded with VN Grant and to represent ENOVAs plans for virtual activities.
Article by ENOVA member Anita Milicic about the history of adjuvants
COST has launched Virtual Networking Support and there are two options available:
Leading Interational Vaccinology Education
A Programme of Excellence in Learning and Research, Looking for Biochemists, Bioengineers, Biologists, Clinicians, Pharmacists and Veterinarians
Open Call: Apply for TRANSVAC2 Vaccine Development Services
ENOVA partners publish review article on the use of adjuvants to boost therapeutic vaccines
WHO today published a "draft landscape of COVID-19 candidate vaccines". A total of 133 vaccines (10 are in clinical trials) covering various platforms (inactivated virus, recombinant virus and proteins, VLPs, DNA/RNA vaccines) are listed. Adjuvants like Alum, Matrix M, AdvaxTM , CPG1018 and others are included as immune stimulants in the race for this vaccine.
Information relating to COVID-19 pandemic from COST can be found here
Reports of ENOVA short term missions are now available on our website
Application for our European Master Erasmus+ dedicated to Vaccinology LIVE is now opened
The Vaccine Formulation Institute (VFI) wishes to recruit a Project Manager to join the VFI Project Management Team in Berlin, Germany. Applications can be submitted until 31 January 2020 to hiring@vformulation.org.
The EU funded project CORBEL (Coordinated Research Infrastructures Building Enduring Life-science Services) have open spots for webinars and courses:
3 positions opened for 2020 in laboratory to work on alternative (host-directed) therapies of bacterial infections. PhD or engineer with strong backgoround in cell biology, immunity or bioinformatics wanted.
For more information, click here
TRANSVAC: European Training in Vaccinology
M10 - Assay Development and Validation-Application of SPR Technologies in Vaccine development and manufacturing.
Venue: Fraunhofer IME, Aachen Germany
Date: 10-11 October 2019
M11 - Process Development and scale-up of recombinant protein vaccines.
Venue: Fraunhofer IME, Aachen Germany
Date: 7-8 October 2019
M12 - Requirements for GMP production
Venue: Fraunhofer IME, Aachen Germany
Date: 14-15 October 2019
TRANSVAC2 project offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. These services are not restricted to any disease in particular.
Except for the few cases indicated on the website, services will be offered free of charge!
Academic and non-academic research groups, SMEs and industries can apply but only to service infrastructures outside their own country.
The fourth call is open from 1 April 2019 – 1st June 2019. It covers 3 modules:
- M6 - CyTOF conducted at CEA, Fontenay-aux-Roses, France (19-20 September 2019)
- M7 - Flow Cytometry organized also by CEA, Fontenay-aux-Roses, France (18-19 September 2019)
- M9 - Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies, organized by VFI together with Merck at Merck/M Lab permises in Molsheim, France (10-11 September 2019)
iCARE-2 is an international fellowship program co-funded by AIRC and the European Union, intended to promote the mobility of experienced researchers to and from Italy. Deadline for submission in June 2019.
TRANSVAC2 project offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. These services are not restricted to any disease in particular.
We have a limited number of places left on the next ENOVA Training School on “Immunoactive carbohydrates and adjuvants: antibacterial vaccines from research to clinical trials” in Sienna which is running from the 2nd to 4th April. The deadline for applications has been extended to March 8th.
The Training School is suitable for Ph.D. students and researchers who have a basic knowledge of analytical and organic chemistry and would like to increase their knowledge of vaccine development specifically in the area carbohydrate-based vaccines.
https://www.enova-adjuvant.eu/training/
On behalf of the XV Congress of the Spanish Society of Virology (Sociedad Española de Virología, SEV) Organizing Committee, it is my great pleasure to welcome you to Barcelona, Spain. The SEV congress will take place on June 9-12th, 2019 at the Axa Auditorium located in one of the most modern areas of the city. More info here.
For the first time, the SEV Congress will be organized together with the Global Virus Network (GVN), an international alliance of centers of excellence in the field of human and animal virology (www.gvn.org); Dr. Christian Bréchot is the president of GVN. This collaboration will increase the scope of our well consolidated SEV Congress and its international visibility.